Company Profile
Crédit Mutuel Equity is the private equity and venture capital arm of Crédit Mutuel Alliance Fédérale, one of France's largest banking groups. Operating for over 40 years, the firm invests its own capital across multiple stages of company development, from seed-phase startups to mature buyouts. The organization combines traditional private equity expertise with a dedicated venture capital entity, Crédit Mutuel Innovation, which manages €3.5 billion in capital and focuses on life sciences, digital, and deep technology companies. The firm's investment philosophy emphasizes long-term partnerships aligned with medium and long-term growth cycles, rather than short-term financial engineering.
Credit Mutuel Equity maintains a distinctive approach centered on human capital and entrepreneurial community building. The firm has cultivated a network of over 350 portfolio company leaders who share experiences and insights across sectors, creating a collaborative ecosystem that extends beyond traditional investor-portfolio company relationships. This community-driven model reflects the firm's belief that human capital drives enterprise value creation. The organization operates with deep regional roots in France while maintaining significant international presence across North America (Canada and the United States) and continental Europe (Germany and Switzerland), enabling portfolio companies to access growth opportunities across multiple markets.
The firm's portfolio spans diverse sectors including travel and tourism (Voyageurs du Monde, a French leader in tailor-made adventure travel), wine production (Tariquet, producing nearly 10 million bottles annually), medical technology (Advitos, developing multi-organ support systems), radiation physics and biology (Alara Group), construction supplies distribution (Au Forum Du Bâtiment with 100 stores across France), and technology solutions (AB Tasty, which raised $40 million in Series C funding). The portfolio companies collectively generate approximately €50 billion in annual turnover and create over 250,000 jobs globally. Recent investments demonstrate focus on transformation across business models, capital structures, and international expansion, with notable 2025-2026 additions including Inelys (accounting and consulting), Palissot (heating and climate systems), EverDye (biosourced textile dyes), and Biomemory (DNA data storage technology).
The leadership team includes Antoine Frey as Chairman and Raphaël Cohen as CEO, supported by experienced investment professionals including Anthony Hillion (Director of Investments in Nantes), Christopher Tournier (General Manager in Paris), and Benoit Herrmann (Investment Director for Credit Mutuel Impact). The firm's expertise spans industrial transformation, technology integration, and international scaling, with particular strength in identifying and supporting companies positioned for disruptive innovation and sustainable growth.
News & Signals (0)
No linked news activity found for this company.
Investor Listings
Private Equity Firms in SwitzerlandHealthcare Private Equity Firms in EuropePrivate Equity Firms in North AmericaTechnology Private Equity Firms in North AmericaPrivate Equity Firms in EuropeVenture Capital Firms in GermanyVenture Capital Firms in SwitzerlandHealthcare Private Equity Firms in North AmericaVenture Capital Firms in North AmericaPrivate Equity Firms in GermanyPrivate Equity Firms in the United StatesTechnology Venture Capital Firms in North AmericaVenture Capital Firms in the United StatesTechnology Venture Capital Firms in EuropePrivate Equity Firms in FranceVenture Capital Firms in ParisIndustrials Private Equity Firms in North AmericaVenture Capital Firms in europePrivate Equity Firms in CanadaPrivate Equity Firms in ParisVenture Capital Firms in FranceTechnology Private Equity Firms in EuropeAgriculture Private Equity Firms in North AmericaVenture Capital Firms in Canada